{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:34:16Z","timestamp":1780922056092,"version":"3.54.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Our study aimed to assess the time to positivity (TTP) of clinically significant blood cultures in critically ill children admitted to the PICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective review of positive blood cultures in patients admitted or transferred to the PICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Large tertiary-care medical center with over 90 PICU beds.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients 0\u201320 years old with bacteremia admitted or transferred to the PICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>The primary endpoint was the TTP, defined as time from blood culture draw to initial Gram stain result. Secondary endpoints included percentage of cultures reported by elapsed time, as well as the impact of pathogen and host immune status on TTP. Host immune status was classified as previously healthy, standard risk, or immunocompromised. Linear regression for TTP was performed to account for age, blood volume, and Gram stain. Among 164 episodes of clinically significant bacteremia, the median TTP was 13.3 hours (interquartile range, 10.7\u201316.8\u2009hr). <jats:italic toggle=\"yes\">Enterobacterales<\/jats:italic>, <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>, <jats:italic toggle=\"yes\">Streptococcus agalactiae<\/jats:italic>, and <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> were most commonly identified. By 12, 24, 36, and 48 hours, 37%, 89%, 95%, and 97% of positive cultures had resulted positive, respectively. Median TTP stratified by host immune status was 13.2 hours for previously healthy patients, 14.0 hours for those considered standard risk, and 10.6 hours for immunocompromised patients (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001). Median TTP was found to be independent of blood volume. No difference was seen in TTP for Gram-negative vs. Gram-positive organisms (12.2 vs. 13.9\u2009hr; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Among critically ill children, 95% of clinically significant blood cultures had an initial positive result within 36 hours, regardless of host immune status. Need for antimicrobial therapy should be frequently reassessed and implementation of a shorter duration of empiric antibiotics should be considered in patients with low suspicion for infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001115","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:00:10Z","timestamp":1720202410000},"page":"e1115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Time to Positive Blood Cultures Among Critically Ill Children Admitted to the PICU"],"prefix":"10.1097","volume":"6","author":[{"given":"Stephanie M.","family":"Yasechko","sequence":"first","affiliation":[{"name":"Division of Pharmacy, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3389-6328","authenticated-orcid":false,"given":"Margot M.","family":"Hillyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G. C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Duke University School of Medicine, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Rodenbough","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred J.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Healthcare of Atlanta, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Division of Pathology, Children\u2019s Healthcare of Atlanta, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Jaggi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"R1-20240806","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis.","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20240806","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fped.2018.00222","article-title":"Time-to-positivity of blood cultures in children with sepsis.","volume":"6","author":"Dierig","year":"2018","journal-title":"Front Pediatr"},{"key":"R4-20240806","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jamapediatrics.2014.895","article-title":"Blood culture time to positivity in febrile infants with bacteremia.","volume":"168","author":"Biondi","year":"2014","journal-title":"JAMA Pediatr"},{"key":"R5-20240806","doi-asserted-by":"crossref","first-page":"5975837","DOI":"10.1155\/2019\/5975837","article-title":"Value of time to positivity of blood culture in children with bloodstream infections.","volume":"2019","author":"Pan","year":"2019","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R6-20240806","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1469-0691.2007.01817.x","article-title":"Time-to-positivity in patients with Escherichia coli bacteraemia.","volume":"13","author":"Peralta","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"R7-20240806","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jpids\/piac084","article-title":"Determining time to positivity of blood cultures in a neonatal unit.","volume":"11","author":"Arias-Felipe","year":"2022","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R8-20240806","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/INF.0000000000002632","article-title":"Time to positivity of neonatal blood cultures for early-onset sepsis.","volume":"39","author":"Kuzniewicz","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20240806","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/jpids\/piv078","article-title":"Time to positivity of blood cultures in infants 0 to 90 days old presenting to the emergency department: Is 36 hours enough?","volume":"6","author":"Lefebvre","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R10-20240806","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.eimc.2017.09.008","article-title":"Blood culture time to positivity in oncology pediatric patients.","volume":"36","author":"Ludwig Sanz-Orrio","year":"2018","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"R14-20240806","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/JCM.02919-15","article-title":"Diagnosis of bloodstream infections in children.","volume":"54","author":"Dien Bard","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R15-20240806","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-3476(96)70388-8","article-title":"Effect of number of blood cultures and volume of blood on detection of bacteremia in children.","volume":"128","author":"Isaacman","year":"1996","journal-title":"J Pediatr"},{"key":"R16-20240806","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1542\/peds.2006-0440","article-title":"How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children\u2019s hospital.","volume":"119","author":"Connell","year":"2007","journal-title":"Pediatrics"},{"key":"R17-20240806","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/BF02185857","article-title":"Importance of blood volume cultured in the detection of bacteremia.","volume":"8","author":"Arpi","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R18-20240806","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/jcm.22.2.292-295.1985","article-title":"Specimen volume versus yield in the BACTEC blood culture system.","volume":"22","author":"Plorde","year":"1985","journal-title":"J Clin Microbiol"},{"key":"R19-20240806","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jpids\/piy043","article-title":"Antibiotic stewardship in the neonatal intensive care unit: Effects of an automatic 48-hour antibiotic stop order on antibiotic use.","volume":"8","author":"Astorga","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R20-20240806","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jpids\/piz064","article-title":"Limiting vancomycin exposure in pediatric oncology patients with febrile neutropenia may be associated with decreased vancomycin-resistant enterococcus incidence.","volume":"9","author":"Karandikar","year":"2020","journal-title":"J Pediatr Infect Dis Soc"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:07:19Z","timestamp":1722982039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":16,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001115","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}